Axsome Therapeutics Inc.
09/16/2021 | Press release | Distributed by Public on 09/16/2021 05:03
Axsome Therapeutics Initiates SYMPHONY Phase 3 Trial of AXS-12 in Narcolepsy
Sharing and Personal Tools
Please select the service you want to use:
Smartlinks | Axsome Therapeutics Inc. | News | Health | Healthcare Policy | Science | Research | Local News | Politics and Policy | Healthcare Policy | Policy and Regulation | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Business Announcement | Products and Services | Corporate Litigation and Regulation | Pharmaceuticals | Public Companies | Pharmaceutical Companies | London Stock Exchange (LSE) | Börse Frankfurt | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | NYSE American | NYSE ARCA Equities | Nasdaq Global Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact